TransEnterix Preps Launch Of Updated Spider Single-Incision Surgical System
This article was originally published in The Gray Sheet
Executive SummaryTransEnterix plans a limited U.S. launch in May of its newly redesigned Spider single-incision surgical system as the Research Triangle Park start-up fine-tunes its focus on the high-growth bariatric surgery space.
You may also be interested in...
Increased fines and penalties are on the cards for manufacturing facilities that fail to comply with proposed new requirements.
The biopharma sector is often accused of a being a slow-moving engine, but a look back over the last 20 years reveals that a lot has changed. In Vivo explores the history of high-impact M&A transactions in the industry between 1999 and 2019.
The Belgian authorities are taking steps to reduce the consumption of benzodiazepine-containing medicines, and have also reiterated the risks associated with the increasing use of opioid medications.